45mon MSN
Michael Kantrowitz, Piper Sandler chief investment strategist, joins 'The Exchange' to discuss why higher rates pose the biggest risks to markets and more.
Piper Sandler initiated coverage of ResMed (RMD) with a Neutral rating and $252 price target While there’s a lot to like about the ResMed ...
Piper Sandler initiated coverage on soda stocks, rating PepsiCo (NASDAQ:PEP), Coca-Cola (NYSE:KO) “overweight,” and Neutral on Keurig Dr Pepper (NASDAQ:KDP).
Piper Sandler dipped into the beverage sector on Tuesday by issuing new Overweight ratings on Coca-Cola (NYSE:KO) and PepsiCo ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Despite recent share appreciation, Piper Sandler believes there is still significant upside for Kenvue. “Though shares have ...
LONDON, January 06, 2025--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Paul Leece, Jeremi Martin and Daniel Allmomen to its energy ...
Nutanix (NTNX) and Twilio (TWLO) are among Piper Sandler's favorite cloud automation software stocks for 2025. Read for ...
BlackLine (NASDAQ:BL – Get Free Report) was downgraded by analysts at Piper Sandler from a “neutral” rating to an “underweight” rating in a research report issued on Monday,Finviz reports. They ...
Piper Sandler downgraded Poseida Therapeutics (PSTX) to Neutral from Overweight with an unchanged price target of $10 following Roche’s announced acquisition for $9 per share in cash and $4 per ...
We recently compiled a list of the 10 Buzzing AI Stocks on Latest News and Ratings. In this article, we are going to take a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback